U.S. Industrial REITs Stock News

NYSE:GRBK
NYSE:GRBKConsumer Durables

Green Brick Partners (GRBK) Margin Compression Reinforces Cautious Narratives Heading Into Q1 2026

Green Brick Partners (GRBK) has just opened Q1 2026 reporting season with a recent run of quarterly results that show total revenue between US$497.6 million and US$567.3 million and basic EPS ranging from US$1.67 to US$2.32 over the last six reported quarters, including net income between US$74.3 million and US$103.1 million. Over the past year, the company has seen trailing twelve month revenue around US$2.1 billion and basic EPS in a tight band between US$7.09 and US$8.51. This gives you a...
NYSE:PAG
NYSE:PAGSpecialty Retail

A Look At Penske Automotive Group (PAG) Valuation After Recent Share Price Momentum

Why Penske Automotive Group is on investors’ radar Penske Automotive Group (PAG) has drawn attention after a solid run, with the stock showing positive returns over the past month and past three months, while continuing to reflect multi year total returns. See our latest analysis for Penske Automotive Group. The recent 7 day share price return of 7.20% and 30 day gain of 14.71%, on a share price of US$171.52, sit alongside a 1 year total shareholder return of 13.85% and 5 year total...
NasdaqGS:MGRC
NasdaqGS:MGRCTrade Distributors

McGrath RentCorp (MGRC) Margin Compression Challenges Bullish Rental Profitability Narratives

McGrath RentCorp (MGRC) opened 2026 with Q1 revenue of about US$198.5 million and basic EPS of roughly US$1.10, while trailing twelve month revenue stood at US$947.4 million with EPS of about US$6.30. The company reported quarterly revenue of US$195.4 million and EPS of roughly US$1.15 in Q1 2025, followed by a peak of US$256.8 million in revenue and EPS of about US$2.02 in Q4 2025 before this latest quarter. This progression provides context for how investors may assess margins as the new...
NYSE:BOX
NYSE:BOXSoftware

Assessing Box (BOX) Valuation As Mixed Returns Contrast With Higher Earnings Multiple

How Box stock has been performing Box (BOX) has seen mixed share performance recently, with a 1 day decline and gains over the past week and month, while returns over the past 3 months and year have been negative. Over the past 5 years, the stock shows a positive total return, in contrast to weaker 3 year and 1 year total returns. Year to date, the share price has also delivered a negative return. See our latest analysis for Box. At a share price of $24.20, Box has seen short term share price...
NYSE:RMD
NYSE:RMDMedical Equipment

ResMed Shifts Leadership And Adds Neurology With Noctrix Acquisition

ResMed (NYSE:RMD) appointed Aaron Bloomer as its new Chief Financial Officer, following the retirement announcement of long-serving CFO Brett Sandercock. The company also agreed to acquire Noctrix Health, a medical device firm focused on treatments for restless leg syndrome. Both announcements highlight changes in financial leadership and an expansion of ResMed’s portfolio beyond its core sleep apnea business. ResMed is best known for its sleep apnea devices and related software, a segment...
NYSE:TDOC
NYSE:TDOCHealthcare Services

Teladoc Health Q1 Loss Reduction Reinforces Bullish Margin Narrative Despite Flat Revenue

Teladoc Health (TDOC) opened 2026 with Q1 revenue of US$613.8 million and a basic EPS loss of US$0.36, alongside a trailing twelve month EPS loss of US$0.96 on revenue of US$2.5 billion. Over recent quarters, the company has seen revenue move from US$629.4 million in Q1 2025 to US$613.8 million in Q1 2026, while quarterly EPS shifted from a loss of US$0.53 to a loss of US$0.36 as net income moved from a loss of US$93.0 million to a loss of US$63.8 million. This keeps the focus firmly on how...
NYSE:BKH
NYSE:BKHIntegrated Utilities

Assessing Black Hills (BKH) Valuation After Recent Share Price Momentum

What recent performance says about Black Hills Black Hills (BKH) has drawn fresh attention after a solid run in its share price, with the stock showing gains over the past week, month, past 3 months and year to date. For investors, that recent performance raises practical questions about how the company’s current US$5.7b market value, US$2.31b in revenue and US$291.6m in net income line up with its role as a regulated electric and natural gas utility. See our latest analysis for Black...
NYSE:THG
NYSE:THGInsurance

Hanover Insurance Group Q1 Margins And EPS Strength Challenge Bearish Earnings Narratives

Hanover Insurance Group (THG) opened 2026 with Q1 revenue of US$1.7 billion and basic EPS of US$5.28, setting the tone for investors watching how its earnings story is developing. The company has seen revenue move from US$1.60 billion in Q1 2025 to US$1.70 billion in Q1 2026, while basic EPS over the same quarters went from US$3.56 to US$5.28. Together with trailing 12 month EPS of US$20.32, this points to a business where profitability and margins are firmly in focus. See our full analysis...
NYSE:BMY
NYSE:BMYPharmaceuticals

Is Bristol Myers Squibb (BMY) Still Attractively Priced After Its Strong 1 Year Share Price Gain

If you are wondering whether Bristol-Myers Squibb at US$60.59 is still offering value or if most of the opportunity is already priced in, the starting point is to understand what the current share price implies about the business. The stock has returned 2.7% over the past week, is roughly flat over 30 days with a 0.1% decline, and is up 13.3% year to date and 28.2% over the last year. This naturally raises questions about how much of this move is tied to changing expectations or perceived...
NYSE:HIMS
NYSE:HIMSHealthcare

Hims And Hers Lawsuits Test Data Security Trust And Stock Valuation

Multiple class action lawsuits allege material data security and privacy failures at Hims & Hers Health, including delayed notification to affected customers. The cases focus on how NYSE:HIMS handled alleged data breaches tied to its digital health platforms. The lawsuits introduce new legal and reputational questions that were not central in earlier discussions of the company. Hims & Hers Health, traded as NYSE:HIMS, sits at the intersection of consumer brands and telehealth, with a...
NasdaqGM:ODD
NasdaqGM:ODDPersonal Products

A Look At Oddity Tech (ODD) Valuation After Class Action Lawsuit On Advertising Disclosures

Class action lawsuit puts Oddity Tech (NasdaqGM:ODD) disclosures in focus A recent notice from The Gross Law Firm about a class action lawsuit against Oddity Tech (NasdaqGM:ODD) alleges misleading statements around digital advertising costs after an algorithm change by its largest advertising partner. See our latest analysis for Oddity Tech. The class action headlines arrive after a sharp reset in sentiment, with a 1 year total shareholder return of about 78% decline and a 90 day share price...
NYSE:IRT
NYSE:IRTResidential REITs

Independence Realty Trust (IRT) Heads Into Q1 2026 With US$285.9m TTM FFO Supporting Bullish Narratives

Independence Realty Trust (IRT) opened Q1 2026 earnings season on the back of recent quarterly figures that included Q4 2025 revenue of US$169.5 million, basic EPS of US$0.14, and funds from operations of US$79.4 million as key markers of operating performance. Over the past year, the company has seen revenue move from US$159.4 million in Q3 2024 to US$169.5 million in Q4 2025, while basic EPS shifted from roughly breakeven in Q4 2024 to US$0.14 in Q4 2025. This sets up a story where higher...
NYSE:URI
NYSE:URITrade Distributors

Assessing United Rentals (URI) Valuation After Strong Recent Share Price Momentum

Event context and recent stock move United Rentals (URI) has recently drawn attention after its share price closed at $959.84, with the stock showing a 0.8% move on the day and mixed returns over the past week and month. See our latest analysis for United Rentals. The recent 1-day share price return of 0.81% comes after a strong 31.74% 1-month share price return and a 51.16% 1-year total shareholder return, suggesting momentum has been building over both shorter and longer periods. If...
NYSE:EMN
NYSE:EMNChemicals

A Look At Eastman Chemical (EMN) Valuation As Shares Trade Near Indicated Discount

Why Eastman Chemical Is On Investors’ Radar Today Eastman Chemical (EMN) is back in focus after recent share price moves, with the stock up over the past week but showing a decline over the past month and mixed returns across longer periods. See our latest analysis for Eastman Chemical. The recent 3.79% 1 day share price return, alongside a 1.63% 7 day share price gain but a 4.23% 30 day share price decline, points to fading short term momentum compared with the stronger 13.60% year to date...
NYSE:ESE
NYSE:ESEMachinery

A Look At ESCO Technologies (ESE) Valuation After Surging Orders And Aerospace And Defense Demand

Investor interest driven by surge in demand Conestoga Capital Advisors recently flagged ESCO Technologies (ESE) as a leading contributor in its first quarter 2026 letter, after sharply higher orders, a larger backlog, and stronger Aerospace & Defense demand drew fresh attention from investors. See our latest analysis for ESCO Technologies. At a share price of $323.95, ESCO Technologies has seen strong momentum recently, with a 30 day share price return of 15.13% and a year to date share price...
NYSE:FCPT
NYSE:FCPTSpecialized REITs

Four Corners Property Trust (FCPT) FFO Trajectory Reinforces Bullish Income Narratives Heading Into Q1 2026

Four Corners Property Trust (FCPT) opened 2026 with Q1 results that build on a steady run of income and cash generation, anchored by Q4 2025 revenue of US$75.7 million, basic EPS of US$0.28 and funds from operations of US$45.7 million. Over the past year, total revenue has moved from US$268.1 million to US$294.1 million on a trailing twelve month basis, while basic EPS tracked from US$1.07 to US$1.09 and FFO reached US$172.7 million, giving investors a clear view of consistent top line and...
NYSE:CTVA
NYSE:CTVAChemicals

Corteva (CTVA) Valuation Check As Mixed Returns Contrast With A Rich P/E Multiple

Why Corteva (CTVA) is on investors’ radar today Corteva (CTVA) is drawing attention after a period of mixed short term share performance, with a 1 day return of 2.07%, a 1 week gain of 1.73%, and a 1 month decline of 3.23%. See our latest analysis for Corteva. The recent 2.07% 1 day share price return and 11.28% 90 day share price return, alongside a 31.90% 1 year total shareholder return and 76.75% 5 year total shareholder return, point to momentum that has been building over time rather...
NasdaqGS:EBAY
NasdaqGS:EBAYMultiline Retail

EBay (EBAY) Q1 2026 Revenue Growth Tests Narrow Vertical Growth Narratives

eBay (EBAY) Q1 2026 results in focus eBay (EBAY) opened 2026 with Q1 revenue of US$3.1b and basic EPS of US$1.14, setting the tone for how its marketplace engine is currently translating volume into earnings. The company reported quarterly revenue of US$2.6b in Q1 2025 and US$3.1b in Q1 2026, while basic EPS over the same period moved from US$1.08 to US$1.14. This gives investors a clearer view of how top line and per share earnings are tracking together. With trailing net margins lower than...
NasdaqGS:HWBK
NasdaqGS:HWBKBanks

Hawthorn Bancshares (HWBK) Margin Strength And 30.4% Earnings Growth Test Cautious Narratives

Hawthorn Bancshares (HWBK) has just posted another set of quarterly numbers, with Q4 2025 revenue of US$25.4 million, basic EPS of US$0.90, and net income of US$6.2 million setting the tone for its latest update. The company has seen revenue move from US$23.3 million and EPS of US$0.66 in Q4 2024 to US$25.4 million and EPS of US$0.90 in Q4 2025. Trailing twelve month net income reached US$23.8 million and basic EPS came in at US$3.43, giving investors a margin profile that looks more...
NasdaqGS:AMKR
NasdaqGS:AMKRSemiconductor

A Look At Amkor Technology (AMKR) Valuation After Record Q1 Results And Major Expansion Plans

Amkor Technology (AMKR) is back in focus after record first quarter 2026 results, upbeat second quarter guidance, fresh capacity expansion in Arizona and Korea, and a new US$300 million share repurchase program. See our latest analysis for Amkor Technology. At a share price of US$69.75, Amkor’s momentum has cooled slightly in the past week, with a 7 day share price return of a 4.33% decline after a sharp 30 day gain of 54.90%. The 1 year total shareholder return of above 7x highlights how...
NYSE:STZ
NYSE:STZBeverage

Is It Time To Reassess Constellation Brands (STZ) After Recent Share Price Pullback?

Wondering whether Constellation Brands at around US$156.58 is starting to offer value, or if the recent price still overstates what you are getting. The stock is up 4.4% over the last 30 days and 10.9% year to date, but sits 13.3% lower over 1 year and 25.1% lower over 3 years. This can change how the market views both its growth potential and risk. Recent news coverage has focused on Constellation Brands as a key player in the beverage space, with ongoing attention on how its brand...
NasdaqGS:OPCH
NasdaqGS:OPCHHealthcare

Is Option Care Health’s (OPCH) Trimmed Revenue Outlook Reframing Its Long-Term Profit Story?

In the past quarter, Option Care Health reported mixed first-quarter 2026 results, with net revenue rising 1.3% year over year to US$1.35 billion while GAAP net income slipped 3.0%, prompting management to trim full-year revenue guidance but maintain adjusted EBITDA and EPS outlooks. A key development was management’s acknowledgement of weakness in its chronic inflammatory disease portfolio alongside plans for operational and commercial changes aimed at reaccelerating growth and improving...
NasdaqCM:CELC
NasdaqCM:CELCBiotechs

Celcuity (CELC) Is Up 6.9% After FDA Grants Priority Review For Gedatolisib And Debt Financing - Has The Bull Case Changed?

In recent months, Celcuity Inc. announced that the FDA granted Priority Review for its lead breast cancer drug candidate gedatolisib, with a PDUFA goal date set for July 2026, while the company began expanding commercial operations and secured US$30.00 million in debt financing. This combination of accelerated regulatory review and a shift toward commercialization marks a major step in Celcuity’s evolution from a research-focused biotech to a potential commercial oncology drug developer...
NYSE:EOG
NYSE:EOGOil and Gas

A Look At EOG Resources (EOG) Valuation As Analyst Optimism Builds Before Earnings

Analyst sentiment around EOG Resources (EOG) has turned more positive ahead of its May 5 quarterly earnings report, with upward revisions to earnings estimates drawing fresh attention from investors watching for potential outperformance. See our latest analysis for EOG Resources. Recent share price moves suggest optimism is building, with a 1-day share price return of 1.04%, 7-day return of 5.00% and 90-day return of 25.36%. The 1-year total shareholder return of 30.35% and 5-year total...